Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
We compare the top Sp 500 index funds by their expense ratios and total fees to help you locate the lowest-cost choice for retirement.
28,029 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Bitcoin has entered a stark profit-and-loss juncture, with a growing share of the supply losing money as prices hover...
Workday delivered a stronger-than-expected earnings beat, but the market fixated on AI-driven demand shifts that coul...
NVIDIA and Alphabet reveal divergent AI strategies, highlighting hardware rails versus cloud-powered services, and si...
AI verification flags a missing proof in a landmark 1976 economic theorem, risking a rethink of models relied upon in...
Investors are backing a new space economy led by SpaceX, with launch costs cratering and Starship on the horizon. Ind...
Dell fell about 6% as memory costs squeezed margins, while Western Digital rose around 5% on continued AI-driven dema...
A major investor moved a sizable stake in Hinge Health, triggering questions about timing and motives. This analysis ...
President Trump signals possible new tariffs during the February State of the Union, renewing a policy debate that co...
Strategy’s stock soared february, jumping 35% from its February low and outpacing bitcoin’s gains as investors price ...
Bitcoin slid to a two-week low near $78,000 after a brief run to the mid-80s, throwing cold water on a quick bear-mar...
Outpoll launches a global prediction market platform, bringing professional tools and API access to a mainstream audi...